Waters Corp Appoints Heather Knight, Baxter Executive, to Board of Directors
Waters Corporation increased its board from 9 to 10 members and appointed Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International, effective August 14, 2024. Her compensation includes an initial equity grant valued at $91,666 and a prorated cash retainer of $54,130 through the 2025 annual meeting, which shareholders will see in the company's disclosures.
- Board expanded from 9 to 10 members on August 13, 2024; Knight's appointment is effective August 14, 2024.
- Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International.
- Initial equity grant valued at $91,666, split 50% restricted stock and 50% non-qualified stock options, vesting on the first anniversary of grant.
- Prorated cash retainer of $54,130 for service until the 2025 annual meeting; the Board determined she is independent under NYSE standards.